CLDT — Chatham Lodging Trust · 2026-09-11 · Verdict: WATCH · Conviction 3
Price $12.95 (screen row, 2026-09-11) · Mkt cap $603M · EV $1,172M · EV/2026E Adj EBITDA 11.6x · P/AFFO 10.9x (ex share-comp add-back) · Net debt $407M · Preferred $120M · ADV $3.4M Sources read: 10-K filed 2026-02-27 (Items 1, 1A, 7), 10-Q filed 2026-08-04, DEF 14A filed 2026-03-31, 8-Ks 2026-05-06 (8-K/A, audited acquisition financials), 2026-05-07, 2026-05-12, 2026-08-04, Form 4s (12m). No call transcript or prepared remarks were filed as an exhibit; management quotes are from the Q2 press release (8-K 2026-08-04, EX-99.1).
Desk stats - Revenue trend: FY2025 revenue $295.1M, down 7.0%, almost entirely the sale of seven hotels, with same-property RevPAR down 0.1% (10-K, Item 7). Q2 2026 revenue $87.8M, up 9.4%, of which $7.3M is the six hotels bought in March and the rest is same-property RevPAR up 3.3%, itself ADR up 3.9% against occupancy down 0.5% (10-Q, Item 2). - Normalised profit (REIT equivalent; no entity-level tax): FY2025 GAAP net income $15,313k, less preferred dividends $(7,950)k, less gain on sale of hotel properties $(14,369)k, plus depreciation of hotel properties $57,664k, gives Nareit FFO of $50,658k; plus finance-lease amortisation $1,887k, other charges $27k and loss on early extinguishment $174k gives Adjusted FFO of $52,746k, or $1.02 per diluted share and unit (10-K, Item 7). 2026 guidance is $63.7M to $66.8M of AFFO, but that now adds back $6.0M of share compensation; on the 2025 definition it is $57.7M to $60.8M, or $1.16 to $1.22 per share (8-K 2026-08-04). - EV / normalised profit: EV of $1,172M is 11.6x the guided $100.75M of 2026 Adjusted EBITDA. Charging the $6.0M of share compensation and a 5%-of-revenue FF&E reserve of $15.7M gives $79.1M, or 14.8x, a 6.7% unlevered yield. At the equity level $12.95 is 10.9x 2026 AFFO on the old definition and about 20x once the full $27M capital budget is charged. - REIT leverage: P/FFO 11.9x on FY2025 Nareit FFO; FFO growth negative three years running; debt/assets 34% on book ($418.2M face against $1,234M of assets) and 24.1% as net debt to hotel investment at cost (10-Q, Item 2). Preferred is 4,800,000 shares of 6.625% Series A, $120M of liquidation preference ahead of the common. - Is the growth sustainable? Mostly bought, not organic: the roughly $8M of 2026 Adjusted EBITDA growth is about the full-year contribution of a portfolio that earned $9.5M of hotel EBITDA in 2025, funded on the revolver, helped by a 3.7% lower share count. Same-property RevPAR is running at 2.3%. - What the screen got wrong: three things, all flattering. Its FFO of $66.9M is net income less preferred plus all D&A, so it never removes the $14.4M gain on hotel sales that Nareit FFO excludes; real FY2025 FFO was $50.7M. Its "FFO growth 17.4%" is entirely that gain rising from $5.7M to $14.4M, while reported FFO fell every year ($56.8M, $54.1M, $50.7M) and AFFO fell too ($59.7M, $55.5M, $52.7M). And its $1,006M EV omits the $120M of preferred and roughly 3.2M operating-partnership units; true EV is about $1,172M.
1. What the business actually does
Chatham owns 39 hotels with 5,610 rooms in 18 states and DC, all upscale extended-stay or premium-branded select-service: sixteen Residence Inns plus Homewood Suites, Home2 Suites, Courtyards, Hampton Inns, Hilton Garden Inns, Hyatt Places and one Embassy Suites (10-K, Item 1; 8-K 2026-08-04). It is internally managed with 16 employees. A REIT cannot operate hotels, so each is leased to a taxable REIT subsidiary that contracts management out. All 39 are managed by Island Hospitality Management, 100% owned by Jeffrey Fisher, the Chairman, President and CEO, for a 3% base fee plus monthly accounting and revenue-management fees and a capped incentive fee: $10.0M in aggregate in 2025 (10-K, Item 1; DEF 14A).
2. Why it is mispriced — the edge case
There is none, and that decides the verdict. Nothing is forcing anyone to sell: the stock is up 82.7% over twelve months and 68.8% over six, and sits 6.1% below its 52-week high on $3.4M of daily volume (screen row). No spin, no index event, no restatement, no strategic review. The 9.0x P/FFO that put it on the screen is the gain-on-sale artifact above, and the preferred the screen ignored is 10% of enterprise value. What remains is an ordinary, well-run small-cap hotel REIT whose price has caught up with its recovery.
3. Unit economics and capital deployment
The operating detail is good. Q2 gross operating profit margin rose 50 basis points to 47% and hotel EBITDA margin 220 basis points to 41%, though a roughly $1M workers' compensation refund flattered the 2025 comparison, without which GOP expansion was 170 basis points; labour and benefits per occupied room rose 3% (8-K 2026-08-04). July RevPAR rose 10% to $169, an all-time July high. Silicon Valley is 17% of trailing hotel EBITDA, then Greater New York, Los Angeles and Washington DC at 9% each.
The March acquisition is the best-evidenced decision here. Chatham paid $92.0M, about $156,000 a room, for six Hilton-branded hotels in Paducah, Joplin and Effingham whose audited 2025 combined accounts show $25.3M of revenue against $14.7M of hotel operating expenses and $1.1M of property taxes and insurance, so $9.5M of hotel EBITDA, a 10.3% trailing cap rate (8-K/A 2026-05-06, EX-99.1), funded on a revolver costing 5.2% (8-K 2026-08-04). That portfolio then grew RevPAR 9% in Q2 and 13% in July. The offset is that it moves the portfolio down the quality curve into small secondary markets with low barriers to new supply.
4. Balance sheet and capital allocation
Debt is $418.2M at 5.84%: $143M of fixed mortgages at 7.2%, $200M of term loan at 5.1%, $75M drawn on a $300M revolver maturing September 2029. The company reports no debt principal payable in the next twelve months and compliance with all covenants at 30 June 2026 (10-Q, Item 2). Leverage of 24.1% of hotel cost is conservative for the sector. Buybacks have been well executed: 2.5M shares, about 5% of shares and units, at an average $7.29, which management calls a 10% capitalisation rate on 2026 corporate net operating income (8-K 2026-08-04). Only $6.6M of the $25M authorisation remained at 30 June and the last tranche was bought at $9.07. Share count fell from 48.98M to 46.57M year over year. The common dividend was raised 11% to $0.10 a quarter in Q1 2026; $0.40 annualised is a 3.1% yield. Donald Smith & Co. owns 10.0%, BlackRock 6.3%, Fisher 5.1% mostly via 1,566,561 LTIP units (DEF 14A). No open-market insider purchases or sales in twelve months across nine Form 4 rows, all grants.
5. Management: what they said versus what they did
Guidance was raised, not cut: between 7 May and 4 August, 2026 Adjusted EBITDA went from $95.3M-$99.6M to $99.2M-$102.3M and AFFO per share from $1.21-$1.29 to $1.28-$1.34. Two caveats. Effective 1 January 2026 the AFFO definition changed to add back share compensation, "like all other peers," raising the headline about 10%; prior periods were recast, so growth rates compare but levels do not against the 2025 filings. And the longer record is unflattering: the 2022 performance LTIPs earned 0% on a missed relative-TSR threshold, the 2025 AFFO-per-share bonus metric came in at $1.02 against a $1.06 target, and the reference price for the February 2023 grant was $12.21, barely below today's price (DEF 14A).
6. Valuation
Base, 50%: 2% RevPAR with flat margins gives about $103M of 2027 Adjusted EBITDA; at today's 11.5x, less $407M net debt and $120M preferred, equity is $658M, or $13.25. Bear, 25%: a mild recession takes RevPAR down 6% with 250 basis points of margin loss, Adjusted EBITDA to about $82M and the multiple to 10x, giving $5.88, with leverage then above 6x EBITDA including preferred. Bull, 25%: 4% RevPAR for two years plus 100 basis points of margin gives $112M at 12.5x, or $17.75. Probability-weighted value is $12.63, about 2% below price. Reverse DCF: at $12.95 the equity yields 6.8% on 2026 AFFO after a normal FF&E reserve, so at a 10% cost of equity the price already implies roughly 3% perpetual growth in after-capex cash flow, against same-property RevPAR of minus 0.1% in 2025 and Smith Travel Research projecting 0.6% industry RevPAR growth for 2026 (10-K, Item 7). The support under the price is replacement cost: EV is about $209,000 per key against the $45M Chatham is itself spending to build 130 suites in Portland, roughly $346,000 per key including commercial space it plans to sell (8-K 2026-08-04).
7. Catalysts and timeline
Q3 results in early November, with July already disclosed at plus 10%. Renovations at San Diego Gaslamp, Homewood Farmington and Hyatt Place Pittsburgh, about $17M of the $27M budget, all begin in Q4 and will displace revenue. A new buyback authorisation, given $6.6M remains. Refinancing of the $143M of 7.2% mortgage debt. The Portland Home2 opens in Q2 2028.
8. Risks and pre-registered kill criteria
Risks: the cycle; 17% Silicon Valley concentration; and a structure in which the CEO owns the manager of all 39 hotels, with the proxy conceding conflicts over whether spending is classified as capital expenditure or repairs, which directly affects his incentive fee (DEF 14A). 1. Same-property RevPAR negative year over year for two consecutive quarters. 2. Full-year hotel EBITDA margin below 34.0%, against 35.5%-36.0% guided. 3. Net debt to hotel investment at cost above 32%, or common equity issued under the $77.5M ATM below $14. 4. 2026 AFFO per share guided below the $1.28 low end.
9. Verdict and one-paragraph summary
WATCH, conviction 3. Chatham is a well-run, conservatively financed hotel REIT that screens cheap for reasons that are not real: the screen's 9.0x P/FFO counts a $14.4M gain on hotel sales as operating cash flow and ignores $120M of preferred, and its "17.4% FFO growth" is that gain growing, while reported FFO actually fell three years running from $56.8M to $50.7M. Corrected, you pay 11.6x 2026 guided EBITDA, 10.9x AFFO on the company's own pre-2026 definition, and about 20x once the $27M capital budget is charged, for a business whose 2026 profit growth is mostly one acquisition plus a 3.7% lower share count rather than organic RevPAR. The capital allocation is admirable, buying six hotels at a 10.3% trailing cap rate with 5.2% money and repurchasing 5% of the company at $7.29, but both were done far below today's price, only $6.6M of the buyback remains, and the stock is up 82.7% in twelve months to sit 6% off its high with no forced seller and no undiscounted catalyst. Probability-weighted value of $12.63 is 2% below price and the reverse DCF already embeds about 3% perpetual growth against an industry Smith Travel Research expects to grow 0.6% this year. The reason to keep watching is the discount to replacement cost, roughly $209,000 a key against the $346,000 Chatham is spending to build in Portland, and a management team that has proven it will buy its own stock when it is cheap. Below about $10 that combination becomes interesting again.
Research for discussion, not investment advice. Positions and sizing are the reader's decision.